Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  BOLSA DE VALORES DE SAO PAULO  >  Fleury SA    FLRY3   BRFLRYACNOR5


End-of-day quote. End-of-day quote  - 09/30
38.64 BRL   --.--%
09/27 NOTICE TO THE M : reduction of ownership participation
09/27 COMUNICADO AO M : redução de participação da Invesco
09/19 FLEURY : Grupo Fleury launches the new version of the Investor Relat..
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Notice to the market: reduction of ownership participation

share with twitter share with LinkedIn share with facebook
share via e-mail
09/27/2016 | 11:20pm CEST


Public Company

CNPJ nº 60.840.055/0001-31 NIRE nº 35.300.197.534

Notice to the market

Reduction of ownership participation

São Paulo, September 27th 2016 -Fleury S.A. ("Grupo Fleury" or "Company"), pursuant to CVM Instruction 358/02, as altered, informs that Invesco Ltd. ("Invesco"), asset manager registered in Securities and Exchange Commission ("SEC") headquartered at 1555 Peachtree Street, N.E., Atlanta, Georgia, 30309, now manages a participation below 5% in the Company's capital due to the sale of its shares on BM&FBOVESPA.

On September 23rd, 2016, Invesco held 7,793,300 shares, representing 4.98% of the share capital of Grupo Fleury.

Invesco states that neither the asset manager nor its customers intend to change the Company's control or its management structure.

Attached there is Invesco's letter to Grupo Fleury.

Adolpho Souza Neto

Investor Relations Officer

Nancy Tomassone Global Assurance Officer


Invesco Ltd.

Two Peachtree Pointe 1555 Peachtree Street NE

Suite 1800 Atlanta GA 30309

Direct 404 479 2926 nancy.tomassone@invesco.com v. ww.invesco. com

September 23, 2016

Adolpho Cyriaco Nunes de Souza neto CFO and IRO

Avenida General Valdomiro de Lima, n° 508; Jabaquara- Sao Paulo

Brazil - 04344 - 903

Re: Disclosure Pursuant to Article 12 of CVM 358

Dear Mr. Adolpho:

Invesco Ltd. is an investment adviser firm registered in the United States with the Securities and Exchange Commission and headquartered at 1555 Peachtree Street, N.E., Atlanta, Georgia, 30309. Invesco Ltd., on behalf of certain of its clients, each of which are investment companies registered under the U.S. Investment Company Act of 1940, as amended, hereby informs you pursuant to article 12 of CVM 358, that we cease to hold 5% of the total outstanding common shares ("TSO") of Fleury SA (the "Company"). We currently hold 7,793,300 shares which represent 4.98% of the TSO of the Company. We emphasize that neither Invesco Ltd. nor its clients have any intention to alter the composition of the control or administrative structures of the Company. In compliance with article 12, paragraph 6 of the Instruction CVM 358, we kindly request the transmission of foregoing, as deemed necessary by the Company, to the Securities and Exchange Commission of Brazil.


Global Assurance Officer

Fleury SA published this content on 27 September 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 27 September 2016 21:20:08 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on FLEURY SA
09/27 NOTICE TO THE MARKET : reduction of ownership participation
09/27 COMUNICADO AO MEFRCADO : redução de participação da Invesco
09/19 FLEURY : Grupo Fleury integrates IBrX100 portfolio
09/19 FLEURY : Grupo Fleury launches the new version of the Investor Relations website
07/29 FLEURY : Financial Statements - 2Q16
07/25 MATERIAL FACT : Stock Option Plan
04/29 FLEURY : Financial Statements - 1Q16
04/08 FLEURY : Notice to the shareholders: dividends
02/03 FLEURY : Notice to the market: transfer of shares - Integritas
2015 FLEURY : Material fact: change of media outlet
More news
Sector news : Medical & Diagnostic Laboratories
09/16 FTSE falls as banking stocks lose ground
09/14DJBusiness Watch -- WSJ
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostics' Billing Processes
09/13DJUNITEDHEALTH : Optum Unit to Oversee Quest Diagnostic's Billing Processes
09/05DJFRESENIUS : to Buy Spanish Hospital Group Quironsalud for 5.76 Billion Euros
More sector news : Medical & Diagnostic Laboratories
Financials ( BRL)
Sales 2016 2 108 M
EBIT 2016 335 M
Net income 2016 184 M
Debt 2016 192 M
Yield 2016 0,88%
P/E ratio 2016 32,52
P/E ratio 2017 24,68
EV / Sales 2016 2,96x
EV / Sales 2017 2,58x
Capitalization 6 039 M
More Financials
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Full-screen chart
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 37,3  BRL
Spread / Average Target -3,5%
Consensus details
EPS Revisions
More Estimates Revisions
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Adolpho Cyriaco Nune de Souza Neto Chief Finance Officer & Head-Investor Relations
Teresa Sacchetta Executive Director-Information Technology
Samuel Monteiro dos Santos Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA145.74%1 855
HCA HOLDINGS INC11.28%28 497
DAVITA INC-6.10%13 544
More Results